Our Research Peptide Catalog BPC-157 - Body Protection Compound, 5mg/10mg vials, 99% purity TB-500 - Thymosin Beta-4 Fragment, 5mg/10mg vials, 99% purity Epithalon - Epitalon tetrapeptide, 10mg/50mg vials, 99% purity GHK-Cu - Copper peptide, 50mg/200mg vials, 99% purity MOTS-C - Mitochondrial peptide, 5mg/10mg vials, 99% purity Ipamorelin - Growth hormone secretagogue, 5mg vials, 99% purity CJC-1295 (no DAC) - GHRH analog, 5mg vials, 99% purity NAD+ - Nicotinamide adenine dinucleotide, 500mg/1000mg vials SLU-PP-332 - Research compound, 50mg vials, 99% purity Nova Triple G - Research peptide blend, 12mg vials Bacteriostatic Water - Sterile reconstitution solution, 10ml vials Quality Standards All NovaCell research peptides undergo rigorous quality control: HPLC Analysis - High-Performance Liquid Chromatography for purity verification LC-MS Testing - Mass spectrometry for molecular identity confirmation COA Documentation - Certificate of Analysis for every batch Lot Tracking - Full traceability from synthesis to delivery EU Shipping Discreet shipping throughout the European Union

Fusion primers with dual-indexed PCR adapters were used to generate the construct library, and short fragments were removed with AMPure beads
MOTS-c A 16-amino-acid peptide encoded within mitochondrial DNA
Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules
Bowcock 2005